Àííîòàöèÿ Ñ öåëüþ àíàëèçà àíòèàðèòìè÷åñêîé ýôôåêòèâíîñòè íèôåðèäèëà ó áîëüíûõ ïàðîêñèçìàëüíûìè íàäæåëóäî÷êîâûìè òàõèêàðäèÿìè è âûÿñíåíèÿ ìåõàíèçìîâ, êîòîðûå ðåàëèçóþòñÿ ïðè äîñòèæåíèè åãî êóïèðóþùåãî è ïðåäóïðåæäàþùåãî àíòèàðèòìè÷åñêîãî äåéñòâèÿ îáñëåäîâàíû 23 áîëüíûõ. | Annotation To analyze antiarrhythmic effectiveness of Niferidil in patients with paroxysmal supraventricular tachycardias and to clarify mechanisms of its curative and protective antiarrhythmic effects, 23 patients were examined. |
Àâòîð Øëåâêîâ, Í. Á., Þðè÷åâà, Þ. À., Ìàðååâ, Þ. Â., ×àçîâ, Å. È., Ñîêîëîâ, Ñ. Ô., Ìèðîíîâ, Í. Þ., Ðîçåíøòðàóõ, Ë. Â., Ãîëèöûí, Ñ. Ï., Ìàéêîâ, Å. Á. | Íîìåðà è ðóáðèêè ÂÀ-¹70 îò 01/12/2012, ñòð. 21 /.. Îðèãèíàëüíûå èññëåäîâàíèÿ |